Find Relief from Depression with Spravato® Treatment in Texas
FDA-approved treatment for adults with treatment-resistant depression, offered in a safe, supportive environment at Prime Psychiatry.
Clinical trials have shown over 60% response rate, and 52% remission rate in patients treated with Spravato® with minimal side effects.
Who can benefit from Spravato®?
Spravato® is FDA-approved to treat two specific types of depression in adults:
- Treatment-Resistant Depression (TRD)
Treatment-resistant depression is depression that does not improve with two or more antidepressants tried at adequate dosages and duration. - Major Depressive Disorder with Suicidal Ideations
If you have major depressive disorder and have expressed suicidal thoughts or behaviors, Our spravato® nasal spray in Plano may be an appropriate next step in treatment.
Spravato
50% - 70%
Response rate
62%
better social functioning
53%
better quality of life
Source:
Affordable, Doctor-Supervised Esketamine Therapy
